Knowledge Tree
Relations (1)
related 2.00 — strongly supporting 3 facts
Psilocybin is identified as a therapeutic agent that induces altered states of consciousness, with its administration sessions used as a benchmark for measuring the duration of these states in clinical models like the Montreal model of ketamine treatment, as described in [1], [2], and [3].
Facts (3)
Sources
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 3 facts
measurementThe Montreal model's six intravenous ketamine treatments provide patients with a similar amount of time in an altered state of consciousness as two doses of psilocybin.
claimThe Montreal model of ketamine treatment spreads the total duration of altered states of consciousness over 4 weeks, whereas psilocybin treatment typically occurs over one or two sessions.
measurementThe Montreal model's six ketamine treatments yield approximately the same amount of time in an altered state of consciousness as 12 psilocybin treatments, but spread out over multiple sessions.